More importantly, previous study has demonstrated that LXR/ApoE axis impairs the viability of MDSCs through LRP8, thus facilitating anti-tumor immunity by activating cytotoxic T lymphocytes (CTLs). This evidence concerns the gene LRP8 and neoplasm.